Who is sponsoring NCT03467841?

NCT03467841 is sponsored by Dr mohammedRmadan hamad.

What drugs are being tested in NCT03467841?

Interventions in NCT03467841: CMV IgM, IgG in blood real time PCR for serum CMV DNA ..

What condition does NCT03467841 study?

NCT03467841 studies Cmv Colitis.

Is NCT03467841 still recruiting?

NCT03467841 is currently status unknown. Last updated 19 March 2018.

Last reviewed 2018-03-19 · How we verify

NCT03467841

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis

Status unknown Last updated 19 March 2018

What this trial tests

trial testing CMV IgM, IgG in blood real time PCR for serum CMV DNA . in Cmv Colitis in 50 participants. Status unknown.

Timeline

1 August 2018

Primary endpoint
1 August 2019

1 September 2019

Quick facts

Lead sponsor	Dr mohammedRmadan hamad
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 August 2018
Primary completion	1 August 2019
Estimated completion	1 September 2019

Drugs / interventions tested

CMV IgM, IgG in blood real time PCR for serum CMV DNA .

Conditions studied

Cmv Colitis — all drugs for Cmv Colitis →

Sponsor

Dr mohammedRmadan hamad

Who can join

Adults 18 to 75, any sex, with Cmv Colitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the work * To identify the prevalence of CMV infection in patients with steroid-refractory ulcerative colitis. * To assess the clinical and endoscopic conditions in these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03467841 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr mohammedRmadan hamad
Last refreshed: 19 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03467841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing